Dr. Adam Charles Breunig, MD

Dr. Breunig practices at Advanced Eye Care in Orlando, Florida.

Dr. Breunig's NPI, 1295999183, was assigned on July 10, 2008. Dr. Breunig graduated from University of Wisconsin-Madison in 2008. Dr. Breunig holds Florida license ME131667.

Dr. Breunig's primary practice is Advanced Eye Care, at 1911 N Mills Ave, Orlando, FL 32803 in Orange County. The practice phone is (407) 893-8200.

Dr. Breunig's primary practice is Advanced Eye Care in Orlando, Florida. Dmand AI also links Dr. Breunig to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Breunig practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Breunig's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Breunig is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Breunig's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Breunig treats.

CMS data shows 1,097 Medicare services from Dr. Breunig across 17 procedure codes in 2024, for 379 Medicare patients. Medicare paid $82,551 for them.

CMS counts 379 Medicare patients who saw Dr. Breunig in 2024. The largest group is 75 to 84, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Breunig's median patient age at 74, with 59% women.

In 2024, Dr. Breunig wrote 6,725 Medicare Part D claims for 1,207 patients. 74% of them were for generic drugs. CMS names the drug for 6,586 of them, across 24 drugs with 11 or more claims each, at $254,678 in total drug cost. In 2023, CMS named 6,033 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Breunig for performance year 2024, reported as part of a group. Dr. Breunig accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 65 procedures of cataract surgery by Dr. Breunig, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Breunig. Dr. Breunig's most frequent co-authors are Mark S. Anderson, MD, Bryce Anthony Binstadt, MD, PhD and Michael S. Lee, MD.

CMS Open Payments shows 60 general payments to Dr. Breunig from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. Alcon Laboratories Inc paid the most, $1,872.

Dmand AI lists 1 award for Dr. Breunig, most recently CMS Stage 1 EHR in 2013.

Dr. Breunig graduated from University of Wisconsin-Madison in 2008.

Dr. Breunig is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.